The online survey conducted by a company that makes a mustache-growth drug called “Mustache” said its “market potential” is “very high.”
The survey, which is still in its early stages, asks its participants to rate the product on a scale of 1 to 5.
Participants can also rate their own experiences with the product.
The survey found that people like to use Mustache, which has a low cost per patient, and also like to grow their hair and beard.
The study found that some of the respondents are not allergic to Mustache.
But it’s not known how many are.
The company says that the survey results could be helpful for those trying to decide between the two products.
It said it’s now offering a $5 discount for anyone who participates in the survey.
Mustache is a synthetic version of a natural ingredient called pomegranate.
It is grown from seeds of the tree Pomegranatum officinalis.
It’s used as an herbal treatment in Asia, Africa and the Middle East.
It can help with digestive issues, hair growth, acne, and the appearance of facial hair.
The mustache product is available through the internet.
The online survey is being conducted by the internet company Dandelion Growth Medicine.
The results of the survey have not been released, and neither has the company.
The company has not responded to The Washington Times’ request for comment.
Follow AP health writer David Allen on Twitter: @davidallenAPHealth,healthcare,bioethics